Many embodiments provide methods of treating cancer using stem cells. In one embodiment the method comprises removing cancer cells from a patient and culturing the cancer cells in the presence of stem cells under conditions such that the stem cells differentiate into stem cell-derived cancer cells ...
JERUSALEM, Oct. 3 (Xinhua) -- Israeli and U.S. researchers found that embryonic stem cells, used for disease treatments and medical researches, may contain cancer mutations, the Hebrew University of Jerusalem (HUJI) reported on Thursday. Embryonic stem cells, which originate in a few-days-old...
cells are rare immortal cells within a tumour that can both self-renew by dividing and give rise to many cell types that constitute the tumour, and can therefore form tumours. Such cells have been found in various types of human tumours and might be attractive targets for cancer treatment. ...
Kim, K. Y., Kim, S. U., Leung, P. C., Jeung, E. B. & Choi, K. C. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.Cancer Sci.101, 955–962 ...
Cancer stem cells, hypoxia and metastasis Semin Radiat Oncol, 19 (2009), pp. 106-111 Google Scholar 38 B. Dave, V. Mittal, N.M. Tan, J.C. Chang Epithelial–mesenchymal transition, cancer stem cells and treatment resistance Breast Cancer Res, 14 (2012), p. 202 Google Scholar 39 A. ...
Nevertheless, pathways that regulate self-renewal and cell fate of normal stem cells, such as Wnt and hedgehog, are also involved in the regulation of cancer stem cells and tumor growth and progression, and may thus represent novel therapeutic targets in cancer treatment. In addition, the ...
Targeting cancer stem cells with polymer nanoparticles for gastrointestinal cancer treatment Yao Sun, Bo Li, Qian Cao, Tongjun Liu & Jiannan Li Stem Cell Research & Therapy volume 13, Article number: 489 (2022) Cite this article 4406 Accesses 23 Citations 1 Altmetric Metrics details Abstract...
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to self-renew themselves and differentiate into heterogeneous lineages of cancer cells. Thus, it is important to understand ...
Our weekly dip into Nature’s archive features progress in radiotherapy for cancer treatment a century ago, and bumblebees cheating to beat their competition. News & Views | 28 January 2025 Breaking up clusters of circulating tumour cells to halt cancer spread A drug that limits the clusterin...
It is much too early to know whether this study in mice will lead to any kind of valuable treatment for humans with cancer. Clinical trials in humans are needed before doctors can know whether stem cells have a role in cancer therapy. Professor Fodde also says that there will be a number...